Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Detection of Streptococcus pneumoniae from culture-negative dried blood spots by real-time PCR in Nigerian children with acute febrile illness.

Iroh Tam PY, Hernandez-Alvarado N, Schleiss MR, Yi AJ, Hassan-Hanga F, Onuchukwu C, Umoru D, Obaro SK.

BMC Res Notes. 2018 Sep 10;11(1):657. doi: 10.1186/s13104-018-3770-2.

2.

Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection".

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Jul 17;92(15). pii: e00771-18. doi: 10.1128/JVI.00771-18. Print 2018 Aug 1. No abstract available.

PMID:
30018144
3.

Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.

Schleiss MR.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6110-6112. doi: 10.1073/pnas.1806420115. Epub 2018 Jun 6. No abstract available.

PMID:
29875141
4.

Searching for a Serological Correlate of Protection for a CMV Vaccine.

Schleiss MR.

J Infect Dis. 2018 May 25;217(12):1861-1864. doi: 10.1093/infdis/jiy104. No abstract available.

PMID:
29528437
5.

Acute Transverse Myelitis Caused by Echovirus 11 in a Pediatric Patient: Case Report and Review of the Current Literature.

Moline HL, Karachunski PI, Strain A, Griffith J, Kenyon C, Schleiss MR.

Child Neurol Open. 2018 Jan 15;5:2329048X17751526. doi: 10.1177/2329048X17751526. eCollection 2018.

6.

Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Mar 14;92(7). pii: e00030-18. doi: 10.1128/JVI.00030-18. Print 2018 Apr 1. Review.

7.

Assessing Zika virus replication and the development of Zika-specific antibodies after a mid-gestation viral challenge in guinea pigs.

Bierle CJ, Fernández-Alarcón C, Hernandez-Alvarado N, Zabeli JC, Janus BC, Putri DS, Schleiss MR.

PLoS One. 2017 Nov 3;12(11):e0187720. doi: 10.1371/journal.pone.0187720. eCollection 2017.

8.

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Schleiss MR, Permar SR, Plotkin SA.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00268-17. doi: 10.1128/CVI.00268-17. Print 2017 Dec. Review.

9.

Congenital Cytomegalovirus Infection: Improved Understanding of Maternal Immune Responses That Reduce the Risk of Transplacental Transmission.

Schleiss MR.

Clin Infect Dis. 2017 Oct 30;65(10):1666-1669. doi: 10.1093/cid/cix626. No abstract available.

PMID:
29020147
10.

Analysis of archived newborn dried blood spots (DBS) identifies congenital cytomegalovirus as a major cause of unexplained pediatric sensorineural hearing loss.

Meyer L, Sharon B, Huang TC, Meyer AC, Gravel KE, Schimmenti LA, Swanson EC, Herd HE, Hernandez-Alvarado N, Coverstone KR, McCann M, Schleiss MR.

Am J Otolaryngol. 2017 Sep - Oct;38(5):565-570. doi: 10.1016/j.amjoto.2017.06.002. Epub 2017 Jun 7.

PMID:
28629849
11.

Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.

Cui X, Adler SP, Schleiss MR, Arav-Boger R, Demmler Harrison GJ, McVoy MA.

Clin Vaccine Immunol. 2017 Jun 5;24(6). pii: e00024-17. doi: 10.1128/CVI.00024-17. Print 2017 Jun.

12.

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.

Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ.

Lancet Infect Dis. 2017 Jun;17(6):e177-e188. doi: 10.1016/S1473-3099(17)30143-3. Epub 2017 Mar 11. Review.

PMID:
28291720
13.

Congenital hearing loss.

Korver AM, Smith RJ, Van Camp G, Schleiss MR, Bitner-Glindzicz MA, Lustig LR, Usami SI, Boudewyns AN.

Nat Rev Dis Primers. 2017 Jan 12;3:16094. doi: 10.1038/nrdp.2016.94. Review.

14.

Cytomegalovirus Vaccines: Current Status and Future Prospects.

Anderholm KM, Bierle CJ, Schleiss MR.

Drugs. 2016 Nov;76(17):1625-1645. Review.

15.

Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.

Schleiss MR, Berka U, Watson E, Aistleithner M, Kiefmann B, Mangeat B, Swanson EC, Gillis PA, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Pinschewer DD, Lilja AE, Schwendinger M, Guirakhoo F, Monath TP, Orlinger KK.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00300-16. doi: 10.1128/CVI.00300-16. Print 2017 Jan.

16.

Cytomegalovirus vaccines under clinical development.

Schleiss MR.

J Virus Erad. 2016 Oct 5;2(4):198-207.

17.

Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.

McVoy MA, Wang JB, Dittmer DP, Bierle CJ, Swanson EC, Fernández-Alarcón C, Hernandez-Alvarado N, Zabeli JC, Schleiss MR.

J Virol. 2016 Aug 12;90(17):7715-27. doi: 10.1128/JVI.00320-16. Print 2016 Sep 1.

18.

Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.

Bierle CJ, Anderholm KM, Wang JB, McVoy MA, Schleiss MR.

J Virol. 2016 Jul 11;90(15):6989-6998. doi: 10.1128/JVI.00139-16. Print 2016 Aug 1.

19.

Does public perception of exposure risks and transmission mechanisms drive antiviral vaccine awareness? What if cytomegalovirus was transmitted by mosquitoes?

Schleiss MR.

Curr Opin Virol. 2016 Apr;17:126-129. doi: 10.1016/j.coviro.2016.03.009. Epub 2016 Apr 22. No abstract available.

PMID:
27107938
20.

Molecular Detection of Streptococcus pneumoniae on Dried Blood Spots from Febrile Nigerian Children Compared to Culture.

Iroh Tam PY, Hernandez-Alvarado N, Schleiss MR, Hassan-Hanga F, Onuchukwu C, Umoru D, Obaro SK.

PLoS One. 2016 Mar 23;11(3):e0152253. doi: 10.1371/journal.pone.0152253. eCollection 2016.

21.

Preventing Congenital Cytomegalovirus Infection: Protection to a 'T'.

Schleiss MR.

Trends Microbiol. 2016 Mar;24(3):170-172. doi: 10.1016/j.tim.2016.01.007. Epub 2016 Feb 6.

22.

Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.

Schleiss MR, Bierle CJ, Swanson EC, McVoy MA, Wang JB, Al-Mahdi Z, Geballe AP.

J Virol. 2015 Oct;89(19):9727-38. doi: 10.1128/JVI.01419-15. Epub 2015 Jul 15.

23.

Limits and patterns of cytomegalovirus genomic diversity in humans.

Renzette N, Pokalyuk C, Gibson L, Bhattacharjee B, Schleiss MR, Hamprecht K, Yamamoto AY, Mussi-Pinhata MM, Britt WJ, Jensen JD, Kowalik TF.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4120-8. doi: 10.1073/pnas.1501880112. Epub 2015 Jul 6.

24.

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.

Swanson EC, Gillis P, Hernandez-Alvarado N, Fernández-Alarcón C, Schmit M, Zabeli JC, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2015 Jul 31;33(32):4013-8. doi: 10.1016/j.vaccine.2015.06.019. Epub 2015 Jun 13.

25.

Epidemic 2014 enterovirus D68 cross-reacts with human rhinovirus on a respiratory molecular diagnostic platform.

McAllister SC, Schleiss MR, Arbefeville S, Steiner ME, Hanson RS, Pollock C, Ferrieri P.

PLoS One. 2015 Mar 23;10(3):e0118529. doi: 10.1371/journal.pone.0118529. eCollection 2015.

26.

Complete genome sequence of cell culture-attenuated Guinea pig cytomegalovirus cloned as an infectious bacterial artificial chromosome.

Yang D, Alam Z, Cui X, Chen M, Sherrod CJ, McVoy MA, Schleiss MR, Dittmer DP.

Genome Announc. 2014 Oct 16;2(5). pii: e00928-14. doi: 10.1128/genomeA.00928-14.

27.

Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

McAllister SC, Schleiss MR.

Expert Rev Vaccines. 2014 Nov;13(11):1349-60. doi: 10.1586/14760584.2014.932694. Epub 2014 Jul 31. Review.

28.

Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.

Gillis PA, Hernandez-Alvarado N, Gnanandarajah JS, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2014 Jun 30;32(31):3963-70. doi: 10.1016/j.vaccine.2014.05.011. Epub 2014 May 20.

29.

Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133.

Gnanandarajah JS, Gillis PA, Hernandez-Alvarado N, Higgins L, Markowski TW, Sung H, Lumley S, Schleiss MR.

Viruses. 2014 Feb 13;6(2):727-51. doi: 10.3390/v6020727.

31.

Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.

Schleiss MR, McAllister S, Armién AG, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Ramaraj T, Crow JA, McVoy MA.

Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448.

33.

Genome Sequence of a Novel, Newly Identified Isolate of Guinea Pig Cytomegalovirus, the CIDMTR Strain.

Schleiss MR, Hernandez-Alvarado N, Ramaraj T, Crow JA.

Genome Announc. 2013 Dec 26;1(6). pii: e01052-13. doi: 10.1128/genomeA.01052-13.

34.

Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent.

Verghese PS, Schleiss MR.

Drugs Future. 2013 May;38(5):291-298.

35.

Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption.

Tengsupakul S, Birge ND, Bendel CM, Reed RC, Bloom BA, Hernandez N, Schleiss MR.

Pediatrics. 2013 Nov;132(5):e1428-34. doi: 10.1542/peds.2013-0087. Epub 2013 Oct 21. Review.

36.

Priorities for CMV vaccine development.

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA.

Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Review.

37.

Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection.

Renzette N, Gibson L, Bhattacharjee B, Fisher D, Schleiss MR, Jensen JD, Kowalik TF.

PLoS Genet. 2013;9(9):e1003735. doi: 10.1371/journal.pgen.1003735. Epub 2013 Sep 26.

38.

Non-immune hydrops fetalis caused by herpes simplex virus type 2 in the setting of recurrent maternal infection.

Pfister KM, Schleiss MR, Reed RC, George TN.

J Perinatol. 2013 Oct;33(10):817-20. doi: 10.1038/jp.2013.68. Review.

PMID:
24071962
39.

Cytomegalovirus in the neonate: immune correlates of infection and protection.

Schleiss MR.

Clin Dev Immunol. 2013;2013:501801. doi: 10.1155/2013/501801. Epub 2013 Aug 19. Review.

40.

An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.

Leviton MP, Lacayo JC, Choi KY, Hernandez-Alvarado N, Wey A, Schleiss MR.

Clin Dev Immunol. 2013;2013:906948. doi: 10.1155/2013/906948. Epub 2013 Aug 20.

41.

Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.

Schleiss MR, Choi KY, Anderson J, Mash JG, Wettendorff M, Mossman S, Van Damme M.

Vaccine. 2014 May 13;32(23):2756-62. doi: 10.1016/j.vaccine.2013.07.010. Epub 2013 Jul 16.

42.

Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Choi KY, Sharon B, Balfour HH Jr, Belani K, Pozos TC, Schleiss MR.

J Clin Virol. 2013 Aug;57(4):356-60. doi: 10.1016/j.jcv.2013.04.004. Epub 2013 May 18.

43.

A comparison of different murine models for cytomegalovirus-induced sensorineural hearing loss.

Wang Y, Patel R, Ren C, Taggart MG, Firpo MA, Schleiss MR, Park AH.

Laryngoscope. 2013 Nov;123(11):2801-6. doi: 10.1002/lary.24090. Epub 2013 Apr 24.

PMID:
23616191
44.

Complete genome sequence of pathogenic Guinea pig cytomegalovirus from salivary gland homogenates of infected animals.

Yang D, Tamburro K, Dittmer D, Cui X, McVoy MA, Hernandez-Alvarado N, Schleiss MR.

Genome Announc. 2013 Mar 14;1(2):e0005413. doi: 10.1128/genomeA.00054-13.

45.

Congenital cytomegalovirus infection: new prospects for prevention and therapy.

Swanson EC, Schleiss MR.

Pediatr Clin North Am. 2013 Apr;60(2):335-49. doi: 10.1016/j.pcl.2012.12.008. Review.

46.

Comparative analysis of detection methods for congenital cytomegalovirus infection in a Guinea pig model.

Park AH, Mann D, Error ME, Miller M, Firpo MA, Wang Y, Alder SC, Schleiss MR.

JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):82-6. doi: 10.1001/jamaoto.2013.1090.

PMID:
23329096
47.

Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145.

Bierle CJ, Schleiss MR, Geballe AP.

Virology. 2012 Nov 10;433(1):157-66. doi: 10.1016/j.virol.2012.08.005. Epub 2012 Aug 20.

48.

Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.

Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF.

Prev Med. 2012 May;54(5):351-7. doi: 10.1016/j.ypmed.2012.03.009. Epub 2012 Mar 21.

49.

Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening.

Schimmenti LA, Warman B, Schleiss MR, Daly KA, Ross JA, McCann M, Jurek AM, Berry SA.

Genet Med. 2011 Dec;13(12):1006-10. doi: 10.1097/GIM.0b013e318226fc2e.

PMID:
21912263
50.

Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Schleiss MR.

Infect Disord Drug Targets. 2011 Oct;11(5):449-65. Review.

Supplemental Content

Loading ...
Support Center